Abiopharma

News list

MICROBOT MEDICAL INC. (MBOT)

SEC News
June 30, 2026, 12:30 UTC

(80% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Regulatory Update

Full text

News bot June 30, 2026, 12:31 p.m.

📋 MICROBOT MEDICAL INC. (MBOT) - Regulatory Update

Filing Date: 2026-06-30

Accepted: 2026-06-30 08:30:20

Event Type: Regulatory Update

Event Details:

MICROBOT MEDICAL INC. (MBOT) Announces Regulatory Update MICROBOT MEDICAL INC. (MBOT) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency) • Status: Rejected Clinical Development:

🔬 Clinical Development Pipeline (MICROBOT MEDICAL INC.):

Product	Type	Development Stage	Therapeutic Area	Source
The LIBERTY® Robotic System	Other	Approved	Peripheral Vascular Interventions	ClinicalTrials.gov

💼 Business Developments:

Partnership
Acquisition: Not available
Licensing: Not available
Regulatory Approval
Executive Changes: Not available

Structured Data:

Company Name: MICROBOT MEDICAL INC.
Ticker Symbol: MBOT